Matthew Heiner

Evaluation of Immunomodulators, Interferons and Known <i>in Vitro</i> SARS-CoV Inhibitors for Inhibition of SARS-Cov Replication in BALB/c Mice

Dale L. Barnard, Craig W. Day, Kevin W. Bailey et al. · Antiviral chemistry & chemotherapy · 2006 · 210 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin

Dale L. Barnard, Craig W. Day, Kevin W. Bailey et al. · Antiviral Research · 2006 · 104 citations

Medicine, Infectious Diseases, Pharmacology +14

Modeling the Offensive-Defensive Interaction and Resulting Outcomes in Basketball

Leonardo Lamas, Felipe Santana, Matthew Heiner et al. · PLoS ONE · 2015 · 62 citations · Full text

Social Sciences, Decision Sciences, Bayesian Data Analysis +6

Protective immunity against acute phleboviral infection elicited through immunostimulatory cationic liposome-DNA complexes

Brian B. Gowen, Jeff Fairman, Donald F. Smee et al. · Antiviral Research · 2006 · 27 citations

Life Sciences, Immunology, Infectious Diseases +15

Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections?

Dale L. Barnard, Craig W. Day, Kevin W. Bailey et al. · Antiviral Research · 2008 · 19 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +7